Azurity Pharmaceuticals Receives FDA Approval for XIFYRM™ Injection to Manage Severe Pain in Adults Azurity Pharmaceuticals has secured FDA approval for XIFYRM™ (meloxicam injection), a breakthrough option for managing moderate-to-severe pain in adults.

Azurity Pharmaceuticals Receives FDA Approval for XIFYRM™ Injection to Manage Severe Pain in Adults #United_States #Azurity_Pharmaceuticals #Woburn #XIFYRM™ #meloxicam_injection